Bringing the fundamentals into focus…
Back to Pacific Biosciences of California, Inc.
How Pacific Biosciences of California, Inc. stacks up
PACB · against 1,336 other Healthcare companies
Valuation
73/ 100
Above the middle of the pack.
Ranked #356 of 1,337 · scores higher than 73% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 70–79, including PACB · Click a bar to see the companies
Why valuation scores 73?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its EBITDA yield, which is stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -17.3% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -16.3% vs peer median 0.0%
- more operating profit (EBITDA) for the company's total value: stronger than 92% of peers. EBITDA yield: 16.2% vs peer median 4.0%
Metric by metric
Position: dot = PACB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PACB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -17.6% | 1.5% | 14% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 16.2% | 4.2% | 92% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -17.2% | -1.0% | 18% | 20% | |
| Book yieldHigher is better · 1,306 reported | -4.4% | 37.9% | 3% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around PACB| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 356 | 15.7B SEK (≈$1.6B) | 73 | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score